Merit Medical Systems, Inc. (MMSI)

NASDAQ: MMSI · Real-Time Price · USD

89.56

+2.40 (2.75%)

At close: Oct 15, 2026, 4:00 PM EDT

89.57

+0.01 (0.01%)

After-hours: Oct 15, 2026, 7:30 PM EDT

Merit Medical Systems Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, Merit Medical Systems stock has a consensus rating of "Buy" and an average price target of $101.64. The average 1-year stock price forecast is 13.49% higher than the current stock price, while the lowest is $83 (-7.32%) and the highest is $123 (+37.34%).

Price Target: $101.64 (+13.49%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$83	$101.64	$100	$123
Change	-7.32%	+13.49%	+11.66%	+37.34%

Analyst Ratings

The average analyst rating for Merit Medical Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	May '26	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26
Strong Buy	4	4	4	4	4	4
Buy	5	5	5	5	5	5
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	11	11	11	11	11	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Michael Petusky Barrington	Barrington	Buy Maintains $114	Buy	Maintains	$114	+27.29%	Oct 12, 2026
Michael Matson Needham	Needham	Buy Reiterates $101	Buy	Reiterates	$101	+12.77%	Sep 29, 2026
Jason Bednar Piper Sandler	Piper Sandler	Buy Maintains $106	Buy	Maintains	$106	+18.36%	Sep 18, 2026
John Young CFA Canaccord Genuity	Canaccord Genuity	Buy Maintains $94	Buy	Maintains	$94	+4.96%	Aug 12, 2026
Sam Eiber BTIG	BTIG	Buy Reiterates $105	Buy	Reiterates	$105	+17.24%	Aug 11, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.64B

from 1.52B

7.95%

from 1.52B

Revenue Next Year

1.74B

from 1.64B

6.07%

from 1.64B

EPS This Year

4.30

from 3.83

12.33%

from 3.83

EPS Next Year

4.61

from 4.30

7.19%

from 4.30

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.07B	1.15B	1.26B	1.36B	1.52B	1.64B
Revenue Growth	11.50%	7.09%	9.24%	7.89%	11.75%	7.95%
Gross Profit	485.33M	519.10M	583.87M	643.33M	738.27M	891.03M
Gross Margin	45.16%	45.10%	46.44%	47.43%	48.70%	54.45%
Operating Income	84.40M	108.26M	135.07M	168.04M	193.90M	347.97M
Net Income	48.45M	74.52M	94.41M	120.36M	128.49M	169.02M
EPS	-	-	-	-	3.83	4.30
EPS Growth	-	-	-	-	10.69%	12.33%
Forward PE	27.70	25.97	24.04	27.13	22.51	20.82
Free Cash Flow	-	-	-	-	215.66M	237.41M
No. Analysts	-	-	-	-	-	11

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	1.6B
Avg	1.6B
Low	1.6B

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	8.2%
Avg	7.9%
Low	7.7%

EPS Forecast

Chart

EPS	2026	2027	2028
High	4.32
Avg	4.30
Low	4.28

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	12.8%
Avg	12.3%
Low	11.7%